Biochemistry, Genetics and Molecular Biology
SMN2
100%
SMN1
100%
Clinical Trial
100%
Medical Genetics
100%
Therapeutic Research
100%
Allele
100%
Lifespan
100%
Survival Rate
100%
Motor Performance
100%
Paralogy
100%
Immunology and Microbiology
Lifespan
100%
Survival Rate
100%
Motor Performance
100%
Paralogy
100%
Therapeutic Research
100%
Allele
100%
Muscle
100%
Keyphrases
Spinal muscular Atrophy
100%
Clinical Trials
14%
Disease Treatment
14%
Quality of Life
14%
Genomic Medicine
14%
Targeted Therapy
14%
FDA-approved Drugs
14%
Poor Prognosis
14%
Disease Mechanisms
14%
Underlying Disease
14%
Disease Severity
14%
Motor Function
14%
Disease-modifying Therapy
14%
Muscle Weakness
14%
Early childhood
14%
Neuromuscular Disease
14%
Survival Rate
14%
Progression Disease
14%
Progressive Paralysis
14%
Therapeutic Research
14%
Atrophy Progression
14%
Natural Progression
14%
Research-clinical
14%
Individual Quality of Life
14%
Complementary Medicine
14%
SMN2
14%
Monogenic Disease
14%
Motor Milestones
14%
SMN1
14%
Paralogous Genes
14%
Pharmacology, Toxicology and Pharmaceutical Science
Spinal Muscular Atrophy
100%
Diseases
42%
Clinical Trial
14%
Survival Rate
14%
Muscle Weakness
14%
Paralysis
14%
Disease Severity
14%
Neuromuscular Disease
14%
Combination Therapy
14%